The lawyers of the Rottenstein Law Group are reviewing the claims of women who believe they have been injured by vaginal mesh products. Any woman who received a vaginal mesh implant and was injured as a result might be eligible for monetary compensation from the mesh product’s manufacturer, whether or not the particular brand of vaginal mesh her doctor used has been recalled or is still on the market. If the manufacturer of a defective surgical mesh, vaginal mesh, or bladder sling failed to warn the public about the risks of using the product, then any woman injured by that product might be eligible to receive a money award if she has suffered any of the following:
- erosion of the mesh product through the vaginal mucosa
- mesh contraction (shrinkage)
- urinary problems
- blood vessel, bladder, or bowel perforation
- vaginal tightening
- dyspareunia (pain during sex) caused by vaginal scarring and vaginal mesh erosion
If you’ve had serious adverse side effects or complications from the transvaginal placement of surgical mesh, submit the simple secure form to the right for a free and confidential evaluation of your eligibility to file a vaginal mesh lawsuit.
U.S. FDA Recognizes the Problem With Mesh Products
The U.S. Food and Drug Administration (FDA) on July 13, 2011, issued a warning specifically addressing the high incidence of complications occurring as a result of using mesh products and slings to treat women’s stress urinary incontinence (SUI) and pelvic organ prolapse (POP)—a condition in which a woman’s bladder, uterus, rectum, vaginal apex, and/or bowels slip down from their normal positions into her vaginal opening. In its report, the FDA noted the following:
- Surgical mesh is a permanent implant that may make future surgical repair more challenging;
- A mesh procedure may put the patient at risk for requiring additional surgery or for the development of new complications;
- Removal of mesh due to mesh complications may involve multiple surgeries and significantly impair the patient’s quality of life. Complete removal of mesh may not be possible and may not result in complete resolution of complications, including pain; and
- Mesh placed abdominally for POP repair may result in lower rates of mesh complications compared to transvaginal POP surgery with mesh.
If you or someone you love has suffered from side effects related to the vaginal placement of surgical mesh, submit the simple secure form on the right so we can conduct a free and confidential evaluation of your eligibility to file a surgical mesh lawsuit. We are sensitive to the suffering that mesh patients have undergone. We will act in your best interests and make the process as simple for you as possible.
Injured Women Are Obtaining Compensation, Regardless of Recall
While many brands of surgical mesh, vaginal mesh, and bladder slings remain on the market, a few have been voluntarily recalled or discontinued. These include the Protegen Sling and ObTape, which were discontinued in 2006. In June 2012, another four vaginal mesh products were voluntarily discontinued, this time by the Johnson & Johnson subsidiary Ethicon: the Prolift, Prolift+ M, TVT Secur, and Prosima systems. The medical device manufacturer Bard took its Avaulta mesh product off the U.S. market in July 2012.
Whether or not the particular brand of vaginal mesh they received has been recalled, victims of vaginal mesh injuries are filing lawsuits to obtain compensation for their injuries. One victim of injuries from vaginal mesh manufactured by C.R. Bard recovered $5.5 million in 2012 after her case was tried in California state court, and a victim of injuries resulting from vaginal mesh manufactured by Johnson & Johnson’s Ethicon unit recovered more than $7 million in 2013 after her case was tried in New Jersey state court. In August 2013, the jury in the first trial of one of the thousands of cases against C.R. Bard pending in West Virginia ordered C.R. Bard to pay $250,000 in compensatory damages and $1.75 million in punitive damages.
Vaginal mesh victims have also recovered settlement awards. In late June 2013, Endo Health Solutions announced that it will pay $55 million to settle an undisclosed number of lawsuits filed by women who claim they suffered serious injuries from vaginal mesh products manufactured by the company’s American Medical Systems unit. In July 2014, C.R. Bard reported to the Securities and Exchange Commission that it had settled more than 500 pending lawsuits involving the Avaulta product line.